SLU-PP 5mg is a synthetic research compound that functions as a selective agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ), targeting cellular energy expenditure, mitochondrial biogenesis, and metabolic regulation. It is utilized in laboratory models to investigate muscle metabolism and endurance optimization pathways. This investigational substance is supplied in 5mg vials and is strictly classified for research purposes with no FDA approval for human use.